Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A Phase I/II Trial Of Concurrent Docetaxel And Concomitant Boost Radiation Therapy For Patients With Squamous Cell Cancer Of The Head And Neck Following Induction Chemotherapy: A Sequential Combined Modality Approach

A Phase I/II Trial Of Concurrent Docetaxel And Concomitant Boost Radiation Therapy For Patients With Squamous Cell Cancer Of The Head And Neck Following Induction Chemotherapy: A Sequential Combined Modality Approach. (ASCO Proc). 2002; 21:2561.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.